Robinhood boosts buyback to $1.5B amid stock slide
Robinhood has approved a new $1.5 billion share repurchase programme as its stock continues to trade well below recent highs.
The buyback adds more than $1.1 billion to existing capacity and is expected to be executed over roughly three years starting in the first quarter of 2026.
The company is not obligated to purchase a fixed amount, but the programme is intended to reduce shares outstanding and support earnings per share.
Alongside the buyback, Robinhood Securities expanded its revolving credit facility to $3.25 billion, with the option to increase it to $4.875 billion, led by JPMorgan.
The move comes after Robinhood shares fell more than 50% since Bitcoin peaked in early October, reversing gains driven by strong crypto trading activity.
Shares rose about 1.4% in after-hours trading following the announcement, suggesting a modest positive reaction from investors.
The combined actions signal a focus on capital management and liquidity as the company navigates a weaker share price environment.
At the time of reporting, Bitcoin price was $70,789.72.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Voices of doubt arise, Moderna CEO reassures the market: Personalized cancer vaccines will cover more types of cancer
Moderna's CEO is highly confident about the prospects of the personalized mRNA cancer vaccine intismeran autogene, stating that it will play a role in more cancers beyond melanoma and drawing parallels with Merck's blockbuster drug Keytruda. Jefferies warns that cross-indication replication is still inconclusive; Citi maintains a "sell" rating, pointing out that commercial application remains limited, with critical issues such as patient suitability, manufacturing, and overall survival data yet to be addressed.
Morgan Stanley Declares U.S. Stock Market Correction Nears End! Maintains Year-End S&P 8000 Target, Identifies Three Major Rebound Catalysts
As Morgan Stanley remains bullish on the stock market, recent market trends have precisely demonstrated the strong rebound momentum of tech stocks dominated by the semiconductor sector. The Philadelphia Semiconductor Index rose by 0.44% on October 23rd and further increased by 2.82% on the 26th.
Eight Highlights of Anthropic IPO Prospectus: Astonishing Growth, but Risks are Obvious
The Anthropic prospectus reveals several highlights: a large-scale enterprise customer base with over 1,900 customers generating more than one million dollars in revenue; as of June 2026, revenue has increased by 1,368% year over year, far surpassing the growth rate of computing costs; positive operating cash flow; and all seven co-founders remain with the company. The company also acknowledges risks, including concentrated supply from TSMC and potential memory chip shortages as significant concerns. October ARR data will be additionally disclosed in a revised version of the document.
Selling Chips, Leasing, Providing Residual Value Support: Broadcom (AVGO.US) Teams Up with Wall Street's Four Giants to Raise $63 Billion to "Inject Funds" for Anthropic's Chip Procurement
Broadcom has reached a $63 billion deal with Bank of America, Blackstone Group, Citigroup, and Morgan Stanley to provide funding for the purchase of chips for AI model developer Anthropic PBC. The transaction is conducted through a newly established special purpose company, which has secured financial commitments from these firms to purchase Broadcom chips and lease them to Anthropic.
Crypto prices
More
